Get started

Catalyst Pharmaceuticals, Inc.

No trades
See on Supercharts
Overview
News Ideas Financials Technicals Forecast

CPRX chart

Key stats

Market capitalization
1.298BUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
11.95
Basic EPS (TTM)
1.10USD
Net income
83.079MUSD
Revenue
214.203MUSD
Shares float
106.583M
Beta
0.74

About Catalyst Pharmaceuticals, Inc.

Sector
Health Technology
CEO
Patrick J. McEnany
Headquarters
Coral Gables
Website
catalystpharma.com
Employees
82
Founded
2002
ISIN
US14888U1016

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing and commercializing novel medicines for patients living with rare diseases including Lambert-Eaton myasthenic syndrome, congenital myasthenic syndromes, MuSK antibody positive myasthenia gravis, spinal muscular atrophy type 3, and infantile spasms. The company was founded by Huckel E. Hubert and Patrick J. McEnany in January 2002 and is headquartered in Coral Gables, FL.

Ideas

Catalyst Pharmaceuticals Short CPRX - waiting for short position. Market almost touched a higher Lin Reg and above MACD on D1. Confirmation: NOT YET !!!!. Red box: Buy area. Suggested TP: Tp1 at $10.40(close 50% of the position) and 2nd at $5.80. Suggested SL: Always follow the Ratio - min 1:3 Warning!!!! This content should not
2
CPRX ready for a good correction. $$As per the image. Key points selling points highlighted in red. Key reinforment poins (long) highlighted in green. Good profit may come your way! I still believe the full correction is yet to come. we may be taking about a couple of weeks away. But it has strong cofirmation points to watch out fo
Long
Long trade in CPRXCPRX is the #1 stock in the biotech group by almost every metric. The table on the chart shows its ranking out of all 795 biotech stocks by 3 metrics from IBD's MarketSmith. Sales and earnings are surging and the rate at which both are growing has increased in each of the last 4 quarters. The sto
Long
Is $CPRX ready to break out of its cup and handle?Notes: * Strong up trend * Okay earnings track record * Basing for the past ~8 weeks * Pulled back to its 10 week line and managed to hold it as support creating a cup and handle pattern * Printed a pocket pivot near its 50 day line offering an early entry and indicating institutional demand T
Long
Long term stock idea: CPRX (Small Cap Biotech) When markets are messy I like to explore long term bases in relatively unknown stocks. CPRX has a 15 year base with contracting volatility in recent years, mostly since 2019. I like the look of the quarterly chart and I like the volume markers on the daily - institutional funds have been progress
Editors' picks
Long
10
Where I'm Buying CPRXCatalyst Pharma (CPRX) is an absolute monster. Not only is the company posting huge sales and earnings growth in a sector that rarely has either, the stock has more than doubled over the last few months. There are 801 stocks in the biotech group tracked by Investors Business Daily, and CPRX ranks a
Long

See all ideas 

News Flow

Keep readingKeep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Financials

Performance
Revenue to profit conversion
Total revenue
Gross profit
EBITDA
EBIT
Net income
‪0%‬
‪0%‬
‪0%‬
‪0%‬
‪0%‬
Debt level and coverage
Earnings
Next:—
‪0‬

Trading & brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
TradeStation
TradeStation
Featured
Stocks, Crypto, Futures
4.4Very Good
Learn more
Interactive Brokers
Interactive Brokers
Stocks, Futures, Bonds
4.3Good
Learn more

See all brokers